(MSSA) isolates. Twenty-four and 22% of MRSA and MSSA isolates, respectively, expressed reduced susceptibility to vancomycin (minimum inhibitory concentration = 3-4 mg/l). Conclusion: The study revealed the presence of methicillin resistance in 32% of S. aureus isolated in Kuwaiti hospitals and revealed an increase in the number of MRSA and MSSA with reduced susceptibility to vancomycin.
Introduction
Staphylococcus aureus remains one of the most frequently isolated pathogens in hospitals and community settings. Methicillin-resistant S. aureus (MRSA) is an important cause of nosocomial and community-acquired infections worldwide. The global epidemiology of MRSA infections is changing significantly. MRSA was initially isolated in healthcare facilities such as hospitals, nursing homes and long-term care facilities [1, 2] and was often resistant also to antibacterial agents such as the aminoglycosides, macrolides, tetracyclines, fluoroquinolones, chloramphenicol, heavy metals and antiseptics, making antibiotic resistance a global public health problem with significant economic and social costs [1, 3, 4] . In recent years, MRSA has also emerged in the community, iso- lated from patients without risk factors traditionally associated with hospital-acquired MRSA, such as recent hospitalization, transfer from another hospital, prior antimicrobial use, invasive procedures and underlying diseases [5, 6] . These new MRSA clones have been described as community-acquired or community-originated MRSA (CA-MRSA) [5] [6] [7] [8] [9] . The CA-MRSA differ from the healthcare-associated MRSA (HA-MRSA) strains phenotypically and genotypically. The CA-MRSA tend to be susceptible to a variety of non-␤ -lactam antibiotics, whereas HA-MRSA are typically resistant to multiple antibiotics [6] [7] [8] [9] . In addition, CA-MRSA strains carry a novel methicillin resistance gene cassette element [staphylococcal cassette chromosome mec (SCC mec ) type IV or V], whereas the HA-MRSA carry SCC mec types I, II and III [6] . The CA-MRSA is now being isolated in hospitals in many countries [6] [7] [8] [9] .
MRSA isolated from patients in Kuwaiti hospitals have been studied previously for their resistance to antibacterial agents [10] [11] [12] . However, data on the prevalence of MRSA as a proportion of S. aureus isolated in these hospitals is limited [13] . In response to this information gap, the present study was conducted to ascertain the prevalence of MRSA among S. aureus isolated in Kuwaiti hospitals.
Materials and Methods

S. aureus Isolates
The surveillance was conducted between 1 March and 30 September 2005 with the participation of 13 hospital-based microbiology laboratories. The hospitals consisted of 2 university-affiliated hospitals and 2 general hospitals with bed capacities 1 500 and smaller general hospitals with ! 500 beds. The participating microbiology laboratories were requested to submit nonduplicate consecutive S. aureus isolates from each patient to the MRSA reference laboratory during the surveillance period. Each participating laboratory provided isolate-level information such as specimen collection date and source (e.g. blood, wound). They also provided some patient details, such as hospital number, location, age, sex and preliminary susceptibility pattern. The isolates were identified by cultural characteristics, growth on mannitol salt agar, Gram's stain and positive tube coagulase test. Isolates were preserved at -80 ° C in 20% (v/v) glycerol and subcultured in brain heart infusion broth and brain heart infusion agar when required.
Antibiotic Susceptibility Testing
Susceptibility testing was performed by the disk diffusion method on Müller-Hinton agar according to the Clinical and Laboratory Standards Institute guidelines [14] . The Clinical and Laboratory Standards Institute susceptibility breakpoints were used for interpretation of inhibition zone diameters except for mupirocin and fusidic acid, which were interpreted based on their minimum inhibitory concentration (MIC) values as described previously [11] . Susceptibility testing for methicillin was performed on Müller-Hinton agar plates with disks containing 5 g of methicillin and incubated at 30 ° C for 24 h. Methicillin resistance was confirmed by detecting PBP2a in culture supernatants using a rapid latex agglutination kit (Denka-Seiken, Japan) according to the manufacturer's instruction. MIC of mupirocin, vancomycin and teicoplanin were determined with E-test strips (AB Biodisk, Solna, Sweden) according to the manufacturer's instructions for the detection of resistance. S. aureus strain ATCC25923 was used for quality control of susceptibility testing. ␤ -Lactamase production was tested with nitrocefin (Oxoid, Basingstoke, UK) according to the manufacturer's instructions. S. aureus strain ATCC29213 was used as a positive control. The differentiation between epidemic MRSA-15 (EMRSA-15) and CA-MRSA was based on susceptibility patterns, urease production and SCC mec typing as reported previously [11] . Multiresistance for MRSA was defined as resistance to 1 3 classes of antibio tics among aminoglycosides, macrolides, tetracyclines, quinolones, rifampicin, chloramphenicol, mupirocin, glycopeptides, trimethoprim and fusidic acid. Nonmultiresistance was defined as resistance to not more than 3 classes of these agents.
Results
During the 7-month surveillance period, a total of 1,846 S. aureus isolates were obtained from different clinical specimens in 13 hospitals. Although the source of S. aureus was not provided for 39.6% of the samples, the major sources of S. aureus were skin/soft tissues (34.8%), nasal swabs (7.5%) and miscellaneous sources which included catheter tips, high vaginal swabs, axilla, eye and semen. A total of 1,765 (95.6%) of the 1,846 S. aureus isolates were from inpatients and only 81 (4.4%) were from outpatients.
The distribution of S. aureus isolates by hospital is presented in table 1 . The data show that 588 isolates constituting 32.0% of the S. aureus isolates were MRSA. A high prevalence of MRSA was observed in Mubarak Al-Kabeer Hospital, which is a university teaching hospital, Ibn Sina Hospital (the only burn centre in the country), AlRazi Hospital (an orthopaedic hospital) and the general hospital at Al-Jahra. No MRSA was isolated at the Infectious Disease and Chest hospitals. A total of 578 (98.0%) MRSA isolates were from inpatients and 10 (2%) were from outpatients. Similarly, 1,187 (94%) of the 1,258 methicillin-susceptible S. aureus (MSSA) were from inpatients and 71 (6.0%) were from outpatients.
Antibacterial Susceptibility Patterns
The antibacterial susceptibilities of both MRSA and MSSA are shown in table 2 . Except for penicillin resis-tance, the proportion of isolates resistant to gentamicin, kanamycin, amikacin, ciprofloxacin, erythromycin, tetracycline, trimethoprim, fusidic acid and mupirocin was higher among MRSA than MSSA isolates. Most of the isolates were susceptible to chloramphenicol, rifampicin and mupirocin, and all were susceptible to linezolid.
Reduced Susceptibility to Vancomycin and Teicoplanin
The distribution of MIC values for vancomycin and teicoplanin showed that 75.9% of MRSA and 77.6% of MSSA had a vancomycin MIC of ^ 2mg/l and 75 and 82% of MRSA and MSSA had a teicoplanin MIC of ^ 2 mg/l. None of the isolates expressed intermediate resistance to vancomycin or teicoplanin (MIC = 8-16 mg/l). However, 24.1 and 24.6% of the MRSA isolates expressed reduced susceptibility to vancomycin and teicoplanin (MIC = 3-4 mg/l), respectively. Similarly, 22.2 and 18.0% of the MSSA isolates expressed reduced susceptibility to vancomycin and teicoplanin (MIC = 3-4 mg/l), respectively.
Nonmultiresistant MRSA
The MRSA isolates were either multiresistant (mMRSA, i.e. resistant to 6 3 classes of non-␤ -lactam antibiotics) or nonmultiresistant (nmMRSA, i.e. resistant to 1 or 2 classes of non-␤ -lactam antibiotics). The proportion of mMRSA and nmMRSA isolates is presented in table 3 .
The nmMRSA comprised 22% of the MRSA isolates and were isolated in 11 of the 13 hospitals. The nmMRSA were further classified as EMRSA-15 and CA-MRSA on the basis of their SCC mec types, phage types, urease and toxin production [15, 16] . Fifty-two (51.5%) of the CA-MRSA were isolated from skin/soft tissue samples. 
Discussion
The results of this study showed that MRSA constituted 32% of all S. aureus isolated in Kuwaiti hospitals. This indicated that the prevalence of MRSA among S. aureus isolates has remained stable in Kuwait since 1996, when it was reported to be 31% of S. aureus isolated in large and small hospitals [13] . MRSA constituted 35% of all S. aureus isolated in a Northern Indian hospital [15] and 47-55% of S. aureus in US hospitals [17] . In the Gulf countries, MRSA constituted 5% of S. aureus isolated in a tertiary hospital in the United Arab Emirates [18] but 38.9% of S. aureus in Saudi Arabian hospitals [16, 19] and 38.8% of S. aureus isolated in an Omani hospital [20] . Bell and Turnidge [21] reported an even higher prevalence of MRSA in other Asian and Western Pacific region countries. The differences in the prevalence of MRSA in different countries emphasize the importance of local surveillance in generating relevant local resistance data that can guide empiric therapy [9] .
This study identified an increase in the proportion nmMRSA among MRSA in Kuwaiti hospitals. The 22% prevalence of nmMRSA observed in this study represents a substantial increase from a prevalence of 5% in Kuwait hospitals between 2000 and 2003 [11] . Furthermore, the nmMRSA were isolated in all of the 11 hospitals where MRSA was detected. Similarly, Asghar and Momenah [16] reported that 21.2% of MRSA in 4 Saudi Arabian hospitals were nmMRSA. The increase in the prevalence of nmMRSA in Kuwait and Saudi Arabia highlights the changing epidemiology of MRSA in these countries, which is consistent with current global trends [6] [7] [8] [9] 17] . The nmMRSA consisted of EMRSA-15 and CA-MRSA. Although both the EMRSA-15 and CA-MRSA have the SCC mec type IV genotype, EMRSA-15 is an epidemic HA-MRSA strain and differs from the CA-MRSA in its lack of the urease enzyme, which results in a negative urease test and weak lysis with phage 75 of the international phage typing set [22] . In contrast, the CA-MRSA produces urease yielding a positive urease test and is lysed by different typing phages [11] . EMRSA-15 is a pandemic MRSA clone that was originally isolated in healthcare facilities in the UK [22] but has now spread internationally [11, 23] . The CA-MRSA is often associated with skin and soft tissue infections in children and young adults [6] . This is consistent with the results that 50% of the CA-MRSA in this study was associated with skin and soft tissue samples. The CA-MRSA was isolated in 2 hospitals in 2003 [11] . Its detection in 11 hospitals in this study indicates that it is now fully established in Kuwaiti hospitals.
This study showed that 24% of MRSA and 22% of MSSA expressed reduced susceptibility to vancomycin (MIC = 3-4 mg/l). This is significant because to date only MRSA isolates have been reported with reduced susceptibility to vancomycin [24] [25] [26] [27] . S. aureus isolates with reduced vancomycin susceptibility is clinically significant because these isolates have been shown to express heterogeneous resistance to vancomycin that resulted in treatment failure [26, 27] . In heterogeneous resistance, a subpopulation of cells expresses resistance, whereas the majority of the cells appear susceptible. The expansion of S. aureus populations with reduced vancomycin susceptibility will further reduce the options available for treating S. aureus infections and put more financial burdens on the healthcare system.
Conclusion
This study showed that 32% of S. aureus isolated in Kuwaiti hospitals during a 7-month period were MRSA. Although the prevalence of MRSA was stable compared to the data obtained in 1996 [14] , there was a shift in the proportion of mMRSA and nmMRSA, with the nmMRSA showing a steady increase while the number of mMRSA isolates were decreasing. The results also revealed an increase in the number of MRSA and MSSA with reduced susceptibility to vancomycin and teicoplanin.
